Vision

Most Recent

Barriers on the Road to New Antibiotics

By | March 14, 2005

Antibiotics have been around since the introduction of penicillin in the 1940s, but the fight against bacterial infections is far from over.

0 Comments

Biotechnology Reenergized

By | March 14, 2005

The completion of the Human Genome Project (HGP) symbolizes the entry of biology into the "big science" arena.

0 Comments

Does Telomerase Moonlight?

By | February 28, 2005

Telomerase, a cellular ribonucleoprotein (RNP) reverse transcriptase, is not detected in most normal human tissues but is almost universally expressed in human cancers.

0 Comments

What Makes a Human?

By | February 28, 2005

Sometimes it is hard to see the forest for the trees.

0 Comments

Challenging Dose-Response Dogma

By | February 14, 2005

The central pillar upon which toxicological assessments are built is the dose-response relationship.

0 Comments

Life Sciences in the 21st Century

By | February 14, 2005

In many ways the laboratory tools we use today may remind us of computers in the late 1970s.

0 Comments

Proteomics Power to the People!

By | January 31, 2005

In the postgenomic era, there are the haves and the have-nots.

0 Comments

Vu for the First Time

By | January 31, 2005

As a culture, we have difficulty letting go of the outdated notion that memory is a reliable tape recorder.

0 Comments

New Frontiers in Commercialization

By | January 17, 2005

Two decades ago, in the high-flying 1980s, there was great hope for licensing newly described molecules, compounds, and targets as potential diagnostic and therapeutic agents.

0 Comments

Twenty Years of The Magnificent Seven

By | January 17, 2005

To any movie buff, TM7 refers to the 1960 John Sturges movie, The Magnificent Seven, in which a 30-year-old Steve McQueen burst onto the scene fighting alongside Yul Brynner, Charles Bronson, Robert Vaughn, and James Coburn to defend the homes of an oppressed Mexican peasant village.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech